Literature DB >> 12810972

Changes in proximal femoral bone mineral density around a hydroxyapatite-coated hip joint arthroplasty.

J C Theis1, G Beadel.   

Abstract

OBJECTIVE: To present the results of a prospective analysis of proximal femoral bone mineral density changes around a hydroxyapatite-coated total hip joint replacement.
METHODS: 14 patients with osteoarthritis of the hip were enrolled in the study and treated with an uncemented ABG prosthesis. Dual energy X-ray absorptiometry scanning was performed in 9 patients preoperatively, and at 3, 6, 12, and 24 months postoperatively. An orthopaedic software program was used to determine the bone mineral density in the proximal femur, expressed as a percentage of the preoperative value.
RESULTS: The values of Gruen zones 1 to 6 averaged between 96.0% and 113.8% of the preoperative value by 24 months (overall average, 104.1%). In zone 7, however, there was a gradual decline in bone mineral density to an average of 72.1% of the preoperative value by 24 months. This represented ongoing loss of bone from the calcar; although this may not pose a problem to the prosthetic's short-term stability, it may render potential revision surgery more difficult.
CONCLUSION: The initial outcome of uncemented total hip replacement appears to be promising. There was excellent maintenance of bone around the femoral component in all regions other than the calcar and lesser trochanter. Further scans are required to see if these trends continue in the long term.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810972     DOI: 10.1177/230949900301100111

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  8 in total

1.  Periprosthetic bone remodeling after 12 years differs in cemented and uncemented hip arthroplasties.

Authors:  Prakash Chandran; Mohammed Azzabi; Mark Andrews; John G Bradley
Journal:  Clin Orthop Relat Res       Date:  2011-10-21       Impact factor: 4.176

2.  [Periprosthetic bone loss after total hip endoprosthesis. Dependence on the type of prosthesis and preoperative bone configuration].

Authors:  A Roth; G Richartz; K Sander; A Sachse; R Fuhrmann; A Wagner; R-A Venbrocks
Journal:  Orthopade       Date:  2005-04       Impact factor: 1.087

3.  Preoperative bone quality as a factor in dual-energy X-ray absorptiometry analysis comparing bone remodelling between two implant types.

Authors:  Bart Cornelis Hendrikus van der Wal; Ali Rahmy; Bernd Grimm; Ide Heyligers; Alphons Tonino
Journal:  Int Orthop       Date:  2006-11-04       Impact factor: 3.075

4.  Changes in periprosthetic bone remodelling after redesigning an anatomic cementless stem.

Authors:  Juan J Panisello; Vicente Canales; Luis Herrero; Antonio Herrera; Jesús Mateo; María J Caballero
Journal:  Int Orthop       Date:  2008-01-11       Impact factor: 3.075

5.  Densitometric evaluation of periprosthetic bone remodeling.

Authors:  Paolo Domenico Parchi; Valentina Cervi; Nicola Piolanti; Gianluca Ciapini; Lorenzo Andreani; Iacopo Castellini; Andrea Poggetti; Michele Lisanti
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

6.  Bone Remodeling of Two Anatomic Stems: Densitometric Study of the Redesign of the ABG-II Stem.

Authors:  Juan J Panisello; Jorge Lopez; Marina Lillo; Jesus Mateo; Carlos Martin; Antonio Herrera
Journal:  Arthroplast Today       Date:  2020-07-03

Review 7.  Hip resurfacing versus total hip arthroplasty: a systematic review comparing standardized outcomes.

Authors:  Deborah A Marshall; Karen Pykerman; Jason Werle; Diane Lorenzetti; Tracy Wasylak; Tom Noseworthy; Donald A Dick; Greg O'Connor; Aish Sundaram; Sanne Heintzbergen; Cy Frank
Journal:  Clin Orthop Relat Res       Date:  2014-04-04       Impact factor: 4.176

8.  Randomised trial comparing bone remodelling around two uncemented stems using modified Gruen zones.

Authors:  René H M ten Broeke; Roel P M Hendrickx; Pieter Leffers; Liesbeth M C Jutten; Rudolph G T Geesink
Journal:  Hip Int       Date:  2012 Jan-Feb       Impact factor: 2.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.